Home / Nervous system / Chlordiazepoxide
ATC N05BA02 · Benzodiazepine Derivatives
Chlordiazepoxide shortage
As of 2 Nov 2026, Chlordiazepoxide has a reported shortage in 3 of the 16 countries we track (Canada, Czechia, Japan), covering 6 products from 3 companies.
Countries3/16
Products6packs or presentations
Companies30 listed
Short since15 Aug 20233.2 years ago
Earliest return1 Jan 2027company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada2 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechia1 product shortNorwayNo reported shortageSwedenNo reported shortageJapan3 products shortNew ZealandNo reported shortageAustraliaNo reported shortage
Timeline
CanadaCzechiaJapan
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group N05BA · Benzodiazepine DerivativesAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | CHLORDIAZEPOXIDE (100 BTL) | AA PHARMA INC | 15 Aug 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | CHLORDIAZEPOXIDE (100 BTL) | AA PHARMA INC | 15 Aug 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CZ | ELENIUM 10MG 10MG TBL OBD 20 | Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A., Varšava | 13 Aug 2026 | 1 Jan 2027 | Manufacturing problem Výrobní důvody |
| JP | クロルジアゼポキシド散1%「ツルハラ」 | 鶴原製薬 | 4 Aug 2026 | not given | Active ingredient shortage Raw material (active ingredient) supply problem |
| JP | クロルジアゼポキシド錠10mg「ツルハラ」 | 鶴原製薬 | 4 Aug 2026 | not given | Active ingredient shortage Raw material (active ingredient) supply problem |
| JP | クロルジアゼポキシド錠5mg「ツルハラ」 | 鶴原製薬 | 4 Aug 2026 | not given | Active ingredient shortage Raw material (active ingredient) supply problem |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.